ARCH Venture Fund XIII, L.P.
Insider trades filed on SEC Form 4, newest first. SEC CIK 0002006772.
- 2
- Form 4 lines on record
- 2
- Purchases (code P)
- 0
- Sales (code S)
- Nov 5, 2026, 6:34 PM ET
- Latest filing
Companies ARCH Venture Fund XIII, L.P. reports for
- Lyell Immunopharma, Inc. LYEL, 10% OwnerLast filed Nov 5, 2026, 5:34 PM ET
Holdings
LockedShares owned after each company's most recent Form 4, valued at the current price. Part of InsiderScanner.
| Filed | Stock | Type | Shares | Price | Value | Traded | Owned after |
|---|---|---|---|---|---|---|---|
| Nov 5, 2026, 5:34 PM ET (open the Form 4 on EDGAR)Purchase (code P) | Buy | Locked | Locked | Locked | Locked | Locked | |
| Mar 9, 2026, 4:34 PM ET (open the Form 4 on EDGAR)Purchase (code P) | Buy | Locked | Locked | Locked | Locked | Locked |
- Filed Nov 5, 2026, 5:34 PM ET (open the Form 4 on EDGAR)Purchase (code P)Buy
LYELLyell Immunopharma, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed Mar 9, 2026, 4:34 PM ET (open the Form 4 on EDGAR)Purchase (code P)Buy
LYELLyell Immunopharma, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
Shares, price, value, trade date and holdings after the trade are locked on 2 rows here. Included with InsiderScanner ($9.99 a month) and Signal8 Pro.
Unlock with InsiderScanner